Clinical, morphological and biochemical effects of antioxidant treatment of patients with chronic hepatitis C.

Karolinska Institutet0 sites30 target enrollmentDecember 20, 2005

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic hepatitis C with moderate to severe liver damage.The patients should not be suitable for standard medical treatment or refuse standard medical treatment for personal reasons.
Sponsor: Karolinska Institutet
Enrollment: 30
Status: Active, not recruiting
Last Updated: 14 years ago

No summary available.

Registry

who.int

Start Date

December 20, 2005

End Date

TBD

Last Updated

14 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

•Chronic hepatitis C with high activity and liver damage (fibrosis stage \>2, inflammation grade \>2 and persistant increase in transaminases, ALAT \>2\). The patient should be non\-responders to conventional therapy or reject therapy. Age \> 20 years old.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range

•Responders to conventional therapy. Low activity and mild liverdamage (fibrosis stage \<2, inflammation grade \<2\), ongoing alcohol abuse, BMI \>30, Pregnancy and lactation.